In an attempt to anticipate the response to mTOR inhibitors, an intriguing study found that the degree of phosphorylated S6 ribosomal protein expression, which indicates mTOR pathway activation, was predictive of early tumor response to the treatment. This evidence concerns the gene RPS6 and neoplasm.